Cullinan Therapeutics, Inc. — Institutional Ownership

Which tracked institutions hold CGEM, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

17
Funds holding
$138913644
Total value held
Buying
14 added/new · 3 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $63234017 4449966 +49670 +1.13%
2 State Street Corp $36151874 2544115 +346777 +15.78%
3 Morgan Stanley $8376558 589483 -177451 -23.14%
4 Bank Of America Corp /De/ $7342649 516724 +170417 +49.21%
5 Goldman Sachs Group Inc $6471930 455449 -266415 -36.91%
6 Northern Trust Corp $6383956 449258 +27623 +6.55%
7 Citigroup Inc $2488730 240457 +133282 +124.36%
8 Prudential Financial Inc $2123613 149445 NEW BUY
9 Bank Of New York Mellon Corp $2042087 143708 -1219 -0.84%
10 Barclays Plc $1993592 140295 NEW BUY
11 Invesco Ltd. $1348844 130323 +28011 +27.38%
12 Wells Fargo & Company/Mn $626320 60514 +21397 +54.70%
13 Janus Henderson Group Plc $263190 18528 NEW BUY
14 Royal Bank Of Canada $58000 4044 NEW BUY
15 Us Bancorp \De\ $7133 502 +19 +3.93%
16 Fifth Third Bancorp $895 63 NEW BUY
17 Pnc Financial Services Group, Inc. $256 18 +13 +260.00%

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.